Surojit Sur - Publications

Affiliations: 
1999 National Chemical Laboratory, Pune, India 

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Nichakawade TD, Ge J, Mog BJ, Lee BS, Pearlman AH, Hwang MS, DiNapoli SR, Wyhs N, Marcou N, Glavaris S, Konig MF, Gabelli SB, Watson E, Sterling C, Wagner-Johnston N, ... ... Sur S, et al. TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers. Nature. PMID 38538786 DOI: 10.1038/s41586-024-07233-2  0.481
2023 Cook AL, Sur S, Dobbyn L, Watson E, Cohen JD, Ptak B, Lee BS, Paul S, Hsiue E, Popoli M, Vogelstein B, Papadopoulos N, Bettegowda C, Gabrielson K, Zhou S, et al. Identification of nonsense-mediated decay inhibitors that alter the tumor immune landscape. Biorxiv : the Preprint Server For Biology. PMID 38234817 DOI: 10.1101/2023.12.28.573594  0.44
2023 Rincon-Torroella J, Molin MD, Mog B, Han G, Watson E, Wyhs N, Ishiyama S, Ahmedna T, Minn I, Azad NS, Bettegowda C, Papadopoulos N, Kinzler KW, Zhou S, Vogelstein B, ... ... Sur S, et al. ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1. Biorxiv : the Preprint Server For Biology. PMID 37546808 DOI: 10.1101/2023.07.23.550207  0.46
2023 Lu S, Mattox AK, Aitana Azurmendi P, Christodoulou I, Wright KM, Popoli M, Chen Z, Sur S, Li Y, Bonifant CL, Bettegowda C, Papadopoulos N, Zhou S, Gabelli SB, Vogelstein B, et al. The rapid and highly parallel identification of antibodies with defined biological activities by SLISY. Nature Communications. 14: 17. PMID 36596784 DOI: 10.1038/s41467-022-35668-6  0.584
2022 Cook AL, Wyhs N, Sur S, Ptak B, Popoli M, Dobbyn L, Papadopoulos T, Bettegowda C, Papadopoulos N, Vogelstein B, Zhou S, Kinzler KW. An isogenic cell line panel for sequence-based screening of targeted anticancer drugs. Iscience. 25: 104437. PMID 35692635 DOI: 10.1016/j.isci.2022.104437  0.43
2021 Paul S, Pearlman AH, Douglass J, Mog BJ, Hsiue EH, Hwang MS, DiNapoli SR, Konig MF, Brown PA, Wright KM, Sur S, Gabelli SB, Li Y, Ghiaur G, Pardoll D, et al. TCR beta chain-directed bispecific antibodies for the treatment of T-cell cancers. Science Translational Medicine. PMID 33649188 DOI: 10.1126/scitranslmed.abd3595  0.662
2016 Sur S, Qiao Y, Fries AC, O’Meally RN, Cole RN, Kinzler KW, Vogelstein B, Zhou S. Abstract 1341: PRINT: A protein bioconjugation method with exquisite N-terminal specificity Cancer Research. 76: 1341-1341. DOI: 10.1158/1538-7445.Am2016-1341  0.474
2015 Sur S, Qiao Y, Fries A, O'Meally RN, Cole RN, Kinzler KW, Vogelstein B, Zhou S. PRINT: A Protein Bioconjugation Method with Exquisite N-terminal Specificity. Scientific Reports. 5: 18363. PMID 26678960 DOI: 10.1038/Srep18363  0.449
2015 Karthikeyan S, Potter JJ, Geschwind JF, Sur S, Hamilton JP, Vogelstein B, Kinzler KW, Mezey E, Ganapathy-Kanniappan S. Deregulation of Energy Metabolism Promotes Antifibrotic Effects in Human Hepatic Stellate Cells and Prevents Liver Fibrosis in a Mouse Model. Biochemical and Biophysical Research Communications. PMID 26525850 DOI: 10.1016/J.Bbrc.2015.10.101  0.419
2015 Sur S, Chapiro J, Savic LJ, Kaniappan GS, Reyes J, Duran R, Thiruganasambandam SC, Moats CR, Luo W, Ewald AJ, Zhou S, Kinzler KW, Geschwind J, Vogelstein B. Abstract NG06: The Trojan Horse Strategy: Packaging chemotherapeutics can help alleviate toxicity Cancer Research. 75. DOI: 10.1158/1538-7445.Am2015-Ng06  0.527
2014 Chapiro J, Sur S, Savic LJ, Ganapathy-Kanniappan S, Reyes J, Duran R, Thiruganasambandam SC, Moats CR, Lin M, Luo W, Tran PT, Herman JM, Semenza GL, Ewald AJ, Vogelstein B, et al. Systemic delivery of microencapsulated 3-bromopyruvate for the therapy of pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6406-17. PMID 25326230 DOI: 10.1158/1078-0432.Ccr-14-1271  0.452
2014 Hendricks WP, Yang J, Sur S, Zhou S. Formulating the magic bullet: barriers to clinical translation of nanoparticle cancer gene therapy. Nanomedicine (London, England). 9: 1121-4. PMID 25118704 DOI: 10.2217/nnm.14.63  0.641
2014 Sur S, Fries AC, Kinzler KW, Zhou S, Vogelstein B. Remote loading of preencapsulated drugs into stealth liposomes. Proceedings of the National Academy of Sciences of the United States of America. 111: 2283-8. PMID 24474802 DOI: 10.1073/Pnas.1324135111  0.427
2014 Ghosh S, Sur S, Yerram SR, Rago C, Bhunia AK, Hossain MZ, Paun BC, Ren YR, Iacobuzio-Donahue CA, Azad NA, Kern SE. Hypersensitivities for acetaldehyde and other agents among cancer cells null for clinically relevant Fanconi anemia genes. The American Journal of Pathology. 184: 260-70. PMID 24200853 DOI: 10.1016/J.Ajpath.2013.09.023  0.692
2013 Ghosh S, Sur S, Yerram SR, Rago C, Bhunia AK, Hossain MZ, Paun BC, Ren YR, Iacobuzio-Donahue CA, Azad NA, Kern SE. Abstract 3580: Acetaldehyde and drug hypersensitivities of Fanconi anemia defects: Implications for cancer initiation, prevention, and therapy. Cancer Research. 73: 3580-3580. DOI: 10.1158/1538-7445.Am2013-3580  0.666
2012 Cui Y, Brosnan JA, Blackford AL, Sur S, Hruban RH, Kinzler KW, Vogelstein B, Maitra A, Diaz LA, Iacobuzio-Donahue CA, Eshleman JR. Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 6519-30. PMID 22753594 DOI: 10.1158/1078-0432.Ccr-12-0827  0.519
2010 Sur S, Mandal SK, Ganesh S, Puranik V, Sarkar A. ChemInform Abstract: High Diastereoselectivity in Hosomi-Sakurai Reaction on Metal-Complexed Acyclic Enones: Role of Out-of-Plane Coordination of Lewis Acid. Cheminform. 33: no-no. DOI: 10.1002/CHIN.200208027  0.457
2010 Sarkar A, Ganesh S, Sur S, Mandal SK, Swamy VM, Maity BC, Kumar TS. ChemInform Abstract: Contra-Intuitive Stereocontrol: endo-Selective Nucleophilic Additions on an Arene-Tricarbonylchromium Template Cheminform. 32: no-no. DOI: 10.1002/CHIN.200132252  0.476
2010 SUR S, GANESH S, PURANIK VG, SARKAR A. ChemInform Abstract: Remote Stereocontrol as a Synthetic Strategy: Diastereoselective Annulations on an Arene Tricarbonylchromium Template. Cheminform. 29: no-no. DOI: 10.1002/CHIN.199826169  0.465
2009 Sur S, Pagliarini R, Bunz F, Rago C, Diaz LA, Kinzler KW, Vogelstein B, Papadopoulos N. A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53. Proceedings of the National Academy of Sciences of the United States of America. 106: 3964-9. PMID 19225112 DOI: 10.1073/Pnas.0813333106  0.697
2003 Posner GH, Paik IH, Sur S, McRiner AJ, Borstnik K, Xie S, Shapiro TA. Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy. Journal of Medicinal Chemistry. 46: 1060-5. PMID 12620083 DOI: 10.1021/Jm020461Q  0.326
2002 Tipparaju SK, Mandal SK, Sur S, Puranik VG, Sarkar A. Cleavage of Si-Ar bond vs Si-Me bond: a remarkable counterion effect on reactivity. Chemical Communications (Cambridge, England). 1924-5. PMID 12271676 DOI: 10.1039/B205373J  0.631
2001 Sarkar A, Ganesh S, Sur S, Mandal SK, Swamy VM, Maity BC, Kumar TS. Contra-intuitive stereocontrol: endo-selective nucleophilic additions on an arene–tricarbonylchromium template Journal of Organometallic Chemistry. 624: 18-25. DOI: 10.1016/S0022-328X(00)00836-6  0.494
1996 Sur S, Ganesh S, Pal D, Puranik VG, Chakrabarti P, Sarkar A. Stereodivergent C−C Bond Formation on Arene−Chromium Template: Endo-Selective Allylation by Hosomi−Sakurai Reaction† The Journal of Organic Chemistry. 61: 8362-8363. DOI: 10.1021/Jo961353C  0.503
Show low-probability matches.